These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4763514)

  • 21. [Immunologic indices of patients with transitional cell carcinoma of the urinary bladder].
    Bkhatta AD; Makhlin NV
    Urol Nefrol (Mosk); 1984; (2):67-70. PubMed ID: 6372193
    [No Abstract]   [Full Text] [Related]  

  • 22. [Immunologic and clinical parameters in patients with bladder cancer].
    Sagaster P; Flamn J; Misksche M
    Wien Med Wochenschr; 1977 May; 127(10):315-9. PubMed ID: 327705
    [No Abstract]   [Full Text] [Related]  

  • 23. [Tumor bladder antigen (TBA). A new method for the diagnosis and detection of recurrence of bladder cancer].
    Escaf Barmadah S; Martín Benito JL; Fernández Gómez JM; San Martín Blanco A; Pérez Gracia FJ; Rodríguez Martínez JJ
    Arch Esp Urol; 1998 Mar; 51(2):129-36. PubMed ID: 9586309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunologic abnormalities in head and neck cancer.
    Eilber FR; Morton DL; Ketcham AS
    Am J Surg; 1974 Oct; 128(4):534-8. PubMed ID: 4422512
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunocompetence and prognosis in patients with gynecologic cancer.
    Nalick RH; Disaia PJ; Rea TH; Morrow CP
    Gynecol Oncol; 1974 Apr; 2(1):81-92. PubMed ID: 4459211
    [No Abstract]   [Full Text] [Related]  

  • 26. Letter: Suppression of delayed hypersensitivity in Graves' disease.
    Joasoo A; Penny R
    Lancet; 1974 Aug; 2(7875):291-2. PubMed ID: 4135718
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of streptococcal preparation (OK-432) local injection in patients with urinary bladder carcinoma.
    Nishio S; Izeki T; Wada S; Morikawa Y; Yasumoto R; Maekawa M
    Osaka City Med J; 1980; 26(1):47-59. PubMed ID: 7267092
    [No Abstract]   [Full Text] [Related]  

  • 28. [Significance of the reactivity to tuberculin, streptokinase and streptodornase in atopic dermatitis].
    Silny W; Wojnerowicz-Grajewska M
    Przegl Dermatol; 1983; 70(3):249-52. PubMed ID: 6665183
    [No Abstract]   [Full Text] [Related]  

  • 29. Initial evaluation of the bladder tumor antigen test in superficial bladder cancer.
    D'Hallewin MA; Baert L
    J Urol; 1996 Feb; 155(2):475-6. PubMed ID: 8558639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The detection of transitional cell bladder cancer antigen on established cell lines.
    Boxer RJ; Sofen H; Saxon A
    Invest Urol; 1981 Sep; 19(2):70-4. PubMed ID: 7024183
    [No Abstract]   [Full Text] [Related]  

  • 31. Enhanced delayed hypersensitivity skin test reactivity with serial testing in healthy volunteers.
    Keystone EC; Demerieux P; Gladman D; Poplonski L; Piper S; Buchanan R
    Clin Exp Immunol; 1980 Apr; 40(1):202-5. PubMed ID: 6993077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Soluble interleukin-2 receptor in patients with urinary bladder cancer].
    Wen R; Xie S
    Zhonghua Zhong Liu Za Zhi; 1996 May; 18(3):224-6. PubMed ID: 9387261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cutaneous immune response to Candidin, PPD and Varidase in cancer patients. Modifying factors].
    Ballesteros P; Cueto J; Rodríguez Rubio P; Talavera C; López Somoza M; Pedraza V; García Puche JL
    Rev Clin Esp; 1980 Oct; 159(1):37-42. PubMed ID: 6936743
    [No Abstract]   [Full Text] [Related]  

  • 34. Nephrotic syndrome as a complication of intravesical BCG treatment of transitional cell carcinoma of urinary bladder.
    Singh NP; Prakash A; Kubba S; Ganguli A; Agarwal SK; Dinda AK; Aggarwal PN
    Ren Fail; 2007; 29(2):227-9. PubMed ID: 17365941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Delayed skin reaction in a group of 400 hospital patients: control study (author's transl)].
    Orriols R; Morell F; Fité E; Ruiz J; Tornos C; Sanz R; Morera J
    Med Clin (Barc); 1981 Oct; 77(6):240-2. PubMed ID: 7321638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune response in bladder cancer patients.
    Brosman S; Elhilali M; Vescera C; Fahey J
    J Urol; 1979 Feb; 121(2):162-9. PubMed ID: 423328
    [No Abstract]   [Full Text] [Related]  

  • 37. Bard BTA test compared with voided urine cytology in the diagnosis of recurrent bladder cancer.
    Leyh H; Mazeman E
    Eur Urol; 1997; 32(4):425-8. PubMed ID: 9412800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma.
    Soga N; Arima K; Sugimura Y
    Int J Urol; 2008 Sep; 15(9):800-3. PubMed ID: 18651862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoprophylactic intravesical application of bacillus Calmette-Guerin after transurethral resection of superficial bladder cancer.
    Librenjak D; Situm M; Eterovic D; Dogas Z; Gotovac J
    Croat Med J; 2003 Apr; 44(2):187-92. PubMed ID: 12698510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
    Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
    J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.